Markets

INCOME STATEMENT

You can view the income statement for the last 5 years.

Aarti Drugs Ltd.

Oct 22 BSE 380.25 ( -9.65 -2.47%)

Volume7086

Prev. Close
389.90

Open Price
388.00

Today's Low / High

372.50 388.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

318.60 533.60

Oct 22 NSE 380.05( -8.55 -2.20%)

Volume159060

Prev. Close
388.60

Open Price
388.90

Today's Low / High

371.00 389.25

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

318.95 534.00

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	2521.28	2368.93	2508.87	2705.57	2488.65
Other Operating Revenues	44.03	18.10	19.71	10.49	0.00
Total Operating Revenues	2565.31	2387.03	2528.58	2716.05	2488.65

Other Income	2.39	16.36	4.03	2.19	11.32
Total Revenue	2567.70	2403.39	2532.61	2718.25	2499.96

EXPENSES
Cost Of Materials Consumed	1480.29	1411.74	1571.98	1768.97	1666.36
Purchase Of Stock-In Trade	115.08	84.34	80.23	121.29	108.57
Operating And Direct Expenses	419.82	374.56	346.28	334.09	295.98
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.37	19.46	25.51	-1.75	-86.08
Employee Benefit Expenses	129.32	112.10	102.34	92.02	82.81
Finance Costs	33.71	35.87	33.52	33.29	20.75
Depreciation And Amortisation Expenses	66.97	55.78	51.45	50.32	50.05
Other Expenses	111.97	97.77	85.77	95.83	91.58
Total Expenses	2356.80	2191.62	2297.08	2494.07	2230.01

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	210.90	211.77	235.53	224.18	269.96

Profit/Loss Before Tax	210.90	211.77	235.53	224.18	269.96

Tax Expenses-Continued Operations
Current Tax	44.55	51.74	59.56	58.86	69.74
Deferred Tax	2.69	2.50	4.37	-1.03	-4.78
Tax For Earlier Years	-31.27	-10.56	0.00	0.00	0.00
Total Tax Expenses	15.96	43.67	63.94	57.82	64.96
Profit/Loss After Tax And Before ExtraOrdinary Items	194.94	168.10	171.59	166.36	205.00

Profit/Loss From Continuing Operations	194.94	168.10	171.59	166.36	205.00

Profit/Loss For The Period	194.94	168.10	171.59	166.36	205.00

Minority Interest	-0.02	0.06	-0.17	-0.05	0.04
Consolidated Profit/Loss After MI And Associates	194.92	168.16	171.42	166.31	205.04

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	21.36	18.35	18.56	17.97	22.12
Diluted EPS (Rs.)	21.36	18.35	18.56	17.97	22.12

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	18.25	9.13	9.19	9.26	9.26

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	2521.28
Other Operating Revenues	44.03
Total Operating Revenues	2565.31
Other Income	2.39
Total Revenue	2567.70
EXPENSES
Cost Of Materials Consumed	1480.29
Purchase Of Stock-In Trade	115.08
Operating And Direct Expenses	419.82
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.37
Employee Benefit Expenses	129.32
Finance Costs	33.71
Depreciation And Amortisation Expenses	66.97
Other Expenses	111.97
Total Expenses	2356.80
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	210.90
Profit/Loss Before Tax	210.90
Tax Expenses-Continued Operations
Current Tax	44.55
Deferred Tax	2.69
Tax For Earlier Years	-31.27
Total Tax Expenses	15.96
Profit/Loss After Tax And Before ExtraOrdinary Items	194.94
Profit/Loss From Continuing Operations	194.94
Profit/Loss For The Period	194.94
Minority Interest	-0.02
Consolidated Profit/Loss After MI And Associates	194.92
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	21.36
Diluted EPS (Rs.)	21.36
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	18.25